Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in Diabet Med

Retrieve available abstracts of 199 articles:
HTML format



Single Articles


    October 2022
  1. WILLIAMS CL, Aitken RJ, Wilson IV, Mortimer GLM, et al
    The measurement of autoantibodies to insulin informs diagnosis of diabetes in a childhood population negative for other autoantibodies.
    Diabet Med. 2022 Oct 17:e14979. doi: 10.1111/dme.14979.
    PubMed     Abstract available


  2. MCCRIMMON RJ
    Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes.
    Diabet Med. 2022 Oct 17:e14973. doi: 10.1111/dme.14973.
    PubMed     Abstract available


    September 2022
  3. DIVILLY P, Zaremba N, Mahmoudi Z, Soholm U, et al
    Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health econom
    Diabet Med. 2022;39:e14892.
    PubMed     Abstract available


    August 2022
  4. DESHMUKH H, Wilmot E, Pieri B, Choudhary P, et al
    Time in Range (TIR) following flash glucose monitoring; relationship with glycaemic control, diabetes-related distress (DRD) and resource utilisation in the Association of British Clinical Diabetologists (ABCD) national audit.
    Diabet Med. 2022 Aug 26:e14942. doi: 10.1111/dme.14942.
    PubMed     Abstract available


  5. BROWN RE, Chu L, Norman GJ, Abitbol A, et al
    Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-C
    Diabet Med. 2022 Aug 18:e14937. doi: 10.1111/dme.14937.
    PubMed     Abstract available


    July 2022
  6. TANENBAUM ML, Zaharieva DP, Addala A, Prahalad P, et al
    "Much more convenient, just as effective:" Experiences of starting continuous glucose monitoring remotely following Type 1 diabetes diagnosis.
    Diabet Med. 2022 Jul 28:e14923. doi: 10.1111/dme.14923.
    PubMed     Abstract available


  7. ITZKOVITZ A, Maggio V, Roy-Fleming A, Legault L, et al
    Nutrition and Food Literacy among Young Canadian Adults Living with Type 1 Diabetes.
    Diabet Med. 2022 Jul 23:e14921. doi: 10.1111/dme.14921.
    PubMed     Abstract available


  8. KERO J, Koskenniemi JJ, Karsikas S, Pokka T, et al
    INnoVative trial design for testing the Efficacy, Safety, and Tolerability of 6-month treatment with incretin-based therapy to prevent type 1 DIAbetes in autoantibody positive participants: a protocol for three parallel double-blind randomised control
    Diabet Med. 2022 Jul 7:e14913. doi: 10.1111/dme.14913.
    PubMed     Abstract available


  9. NG SM, Katkat N, Day H, Hubbard R, et al
    Real-world prospective observational single-centre study: Hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers.
    Diabet Med. 2022;39:e14863.
    PubMed     Abstract available


  10. MESSER LH, Vigers T, Pyle L, Fivekiller E, et al
    Novel predictors of daily fluctuations in glycemia and self-management in adolescents and young adults with type 1 diabetes.
    Diabet Med. 2022 Jul 1:e14910. doi: 10.1111/dme.14910.
    PubMed     Abstract available


    June 2022
  11. ROBERTS A, Fried L, Dart J, de Bock M, et al
    Hybrid closed loop therapy with a first-generation system increases confidence and independence in diabetes management in youth with Type 1 diabetes.
    Diabet Med. 2022 Jun 27:e14907. doi: 10.1111/dme.14907.
    PubMed     Abstract available


  12. FALLON C, Jones E, Oliver N, Reddy M, et al
    The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes.
    Diabet Med. 2022 Jun 25:e14906. doi: 10.1111/dme.14906.
    PubMed     Abstract available


  13. SONG SH, Frier BM
    Young-onset type 2 diabetes: a neglected group requiring urgent attention.
    Diabet Med. 2022 Jun 18:e14903. doi: 10.1111/dme.14903.
    PubMed    


  14. INNES CWD, Henshall DE, Wilson B, Poon MTC, et al
    Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for people with type 1 diabetes.
    Diabet Med. 2022 Jun 18:e14902. doi: 10.1111/dme.14902.
    PubMed     Abstract available


    May 2022
  15. ABRAIMOVA A, Besancon S, Portocarrero J, Ramaiya K, et al
    Management of type 1 diabetes in low- and middle-income countries: comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.
    Diabet Med. 2022 May 27:e14891. doi: 10.1111/dme.14891.
    PubMed     Abstract available


  16. FANG X, Jin L, Tang M, Lu W, et al
    Common single-nucleotide polymorphisms Combined with a Genetic Risk Score Provide New Insights Regarding the Etiology of Gestational Diabetes Mellitus.
    Diabet Med. 2022 May 19:e14885. doi: 10.1111/dme.14885.
    PubMed     Abstract available


  17. LEE VTY, Poynten A, Depczynski B
    Continuous Glucose Monitoring to Assess Glucose Variability in Type 3c Diabetes.
    Diabet Med. 2022 May 15:e14882. doi: 10.1111/dme.14882.
    PubMed     Abstract available


  18. JOENSEN LE, Schultz AA, Madsen KP, Persson F, et al
    Flexible inclusion of dialogue about psychosocial aspects of life with type 1 diabetes in routine consultations - a study of a questionnaire-based dialogue tool to promote person-centered support.
    Diabet Med. 2022 May 13:e14881. doi: 10.1111/dme.14881.
    PubMed     Abstract available


  19. CLEAL B, Willaing I
    User-driven, open-source diabetes technology: Challenges and opportunities in diabetes care?
    Diabet Med. 2022;39:e14836.
    PubMed    


  20. VALLIS M, Holt RIG
    User-driven open-source artificial pancreas systems and patient-reported outcomes: A missed opportunity?
    Diabet Med. 2022;39:e14797.
    PubMed     Abstract available


  21. CAMERLINGO N, Vettoretti M, Sparacino G, Facchinetti A, et al
    Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: A new analytical approach to overcome the limitations of correlation-based methods.
    Diabet Med. 2022;39:e14758.
    PubMed     Abstract available


  22. CROCKET H, Lewis DM, Burnside M, Faherty A, et al
    Learning challenges of healthcare professionals supporting open-source automated insulin delivery.
    Diabet Med. 2022;39:e14750.
    PubMed     Abstract available


  23. CROCKET H, Elbashy MM, Kavanagh T, Styles S, et al
    Parental experiences of short term supported use of a do-it-yourself continuous glucose monitor (DIYrtCGM): A qualitative study.
    Diabet Med. 2022;39:e14731.
    PubMed     Abstract available


  24. DICKSON R, Bell J, Dar A, Downey L, et al
    #WeAreNotWaiting DIY artificial pancreas systems and challenges for the law.
    Diabet Med. 2022;39:e14715.
    PubMed     Abstract available


  25. LEWIS DM
    Errors of commission or omission: The net risk safety analysis conversation we should be having around automated insulin delivery systems.
    Diabet Med. 2022;39:e14687.
    PubMed     Abstract available


    April 2022
  26. TATOVIC D, Jones AG, Evans C, Long AE, et al
    Diagnosing Type 1 diabetes in adults: guidance from the UK T1D Immunotherapy consortium.
    Diabet Med. 2022 Apr 29:e14862. doi: 10.1111/dme.14862.
    PubMed    


  27. ARIF S, Yusuf N, Domingo-Vila C, Liu YF, et al
    Evaluating T cell responses prior to the onset of type 1 diabetes.
    Diabet Med. 2022 Apr 28:e14860. doi: 10.1111/dme.14860.
    PubMed     Abstract available


  28. SUGRUE M, Liddy AM, McDermott JH, Sreenan S, et al
    Diabetic Ketoacidosis as a Unique Presentation of Cystic Fibrosis.
    Diabet Med. 2022 Apr 25:e14859. doi: 10.1111/dme.14859.
    PubMed    


  29. BUSKOVEN MEH, Kjorholt EKH, Strandberg RB, Softeland E, et al
    Sexual dysfunction in women with type 1 diabetes in Norway: A qualitative study of women's experiences.
    Diabet Med. 2022 Apr 23:e14856. doi: 10.1111/dme.14856.
    PubMed     Abstract available


  30. ELBALSHY M, Haszard J, Smith H, Kuroko S, et al
    Effect of Divergent Continuous Glucose Monitoring Technologies on Glycaemic Control in Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Diabet Med. 2022 Apr 20:e14854. doi: 10.1111/dme.14854.
    PubMed     Abstract available


  31. MOSHAGE Y, Rodrigues F, White M, Cameron F, et al
    A pragmatic real world trial examining the impact of an alteration of prescribing practice at diagnosis in pediatric type 1 diabetes mellitus.
    Diabet Med. 2022 Apr 15:e14849. doi: 10.1111/dme.14849.
    PubMed    


  32. MACKENZIE SC, Cumming KM, Mehar S, Wilson L, et al
    Education at Scale: Improvements in Type 1 Diabetes Self-Management Following a Massive Open Online Course (MOOC).
    Diabet Med. 2022 Apr 15:e14842. doi: 10.1111/dme.14842.
    PubMed    


    March 2022
  33. DINNEEN SF, McMorrow L
    Re-framing type 1 diabetes care through Open-source Automated Insulin Delivery: "The (expert) patient will see you now, doctor".
    Diabet Med. 2022 Mar 31:e14839. doi: 10.1111/dme.14839.
    PubMed    


  34. JONES PM, Persaud SJ
    beta-cell replacement therapy for type 1 diabetes: closer and closer.
    Diabet Med. 2022 Mar 27:e14834. doi: 10.1111/dme.14834.
    PubMed    


  35. SEIDEL-JACOBS E, Ptushkina V, Strassburger K, Icks A, et al
    Socioeconomic Inequalities in Glycaemic Control in Recently Diagnosed Adults with Type 1 and Type 2 Diabetes.
    Diabet Med. 2022 Mar 24:e14833. doi: 10.1111/dme.14833.
    PubMed     Abstract available


  36. MASHARANI U, Strycker LA, Fisher L
    The ubiquity of diabetes distress among adults with type 1 diabetes in an urban, academic practice: a template for intervention.
    Diabet Med. 2022 Mar 24:e14832. doi: 10.1111/dme.14832.
    PubMed     Abstract available


  37. ISITT JJ, Roze S, Tilden D, Arora N, et al
    Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes IN Australia.
    Diabet Med. 2022 Mar 17:e14831. doi: 10.1111/dme.14831.
    PubMed     Abstract available


  38. JESSICA E, Anna-Maria L, Sofia C
    Parental smoking, type 1 diabetes, and islet antibody positivity in the offspring: a systematic review and meta-analysis.
    Diabet Med. 2022 Mar 15:e14830. doi: 10.1111/dme.14830.
    PubMed     Abstract available


  39. HART RI, Kimbell B, Rankin D, Allen JM, et al
    Parents' experiences of using remote monitoring technology to manage type 1 diabetes in very young children during a clinical trial: qualitative study.
    Diabet Med. 2022 Mar 11:e14828. doi: 10.1111/dme.14828.
    PubMed     Abstract available


    February 2022
  40. BASHIR B, Elisaus P, Grigoriadou VC, Urwin A, et al
    Real world effectiveness of clinically approved hybrid closed loop systems in a UK Secondary Care Diabetes Service.
    Diabet Med. 2022 Feb 18:e14816. doi: 10.1111/dme.14816.
    PubMed    


  41. TAYLOR G, Shaw AC, Smith K, Wason J, et al
    Capturing the real world benefit of residual beta-cell function during clinically important time-periods in established Type 1 diabetes.
    Diabet Med. 2022 Feb 18:e14814. doi: 10.1111/dme.14814.
    PubMed     Abstract available


  42. DYBJER E, Dahl Aslan AK, Engstrom G, Nilsson ED, et al
    Type 1 diabetes, cognitive ability and incidence of cardiovascular disease and death over 60 years of follow-up time in men.
    Diabet Med. 2022 Feb 7:e14806. doi: 10.1111/dme.14806.
    PubMed     Abstract available


  43. ZAFRA-TANAKA JH, Beran D, Bernabe-Ortiz A
    Health system responses for type 1 diabetes: A scoping review.
    Diabet Med. 2022 Feb 5:e14805. doi: 10.1111/dme.14805.
    PubMed     Abstract available


    January 2022
  44. CARLSON NE, Horton KW, Hokanson JE, Cleary PA, et al
    Weight gain trajectories and obesity rates in intensive and conventional treatments of Type 1 diabetes from the DCCT compared to a control population without diabetes.
    Diabet Med. 2022 Jan 18:e14794. doi: 10.1111/dme.14794.
    PubMed     Abstract available


  45. PATEL R, Crabtree T, Taylor N, Langeland L, et al
    Safety and effectiveness of Do-It-Yourself Artificial Pancreas System (DIYAPS) compared with continuous subcutaneous insulin infusions (CSII) in combination with Free Style Libre (FSL) in people with Type 1 diabetes.
    Diabet Med. 2022 Jan 16:e14793. doi: 10.1111/dme.14793.
    PubMed     Abstract available


  46. BAHRAMI J, Tomlinson G, Murphy HR, Feig DS, et al
    Impaired Awareness of Hypoglycaemia in Women with Type 1 Diabetes in Pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes.
    Diabet Med. 2022 Jan 14:e14789. doi: 10.1111/dme.14789.
    PubMed     Abstract available


  47. LAURBERG T, Schougaard LMV, Hjollund NHI, Lomborg KE, et al
    Randomized Controlled Study to Evaluate the Impact of Flexible Patient-controlled Visits in People with Type 1 Diabetes: The DiabetesFlex Trial.
    Diabet Med. 2022 Jan 13:e14791. doi: 10.1111/dme.14791.
    PubMed     Abstract available


  48. DE LEUR K, Vollenbrock C, Dekker P, de Vries M, et al
    How low is really low? Comparison of two C-peptide assays to establish residual C-peptide production in type 1 diabetes.
    Diabet Med. 2022 Jan 6:e14785. doi: 10.1111/dme.14785.
    PubMed     Abstract available


  49. BOCHANEN N, Decochez K, Heleu E, Cuypers J, et al
    Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
    Diabet Med. 2022;39:e14672.
    PubMed     Abstract available


    December 2021
  50. LADD JM, Reeves-Latour J, Dasgupta K, Bell LE, et al
    Toward a better understanding of transition from paediatric to adult care in type 1 diabetes: a qualitative study of adolescents.
    Diabet Med. 2021 Dec 29:e14781. doi: 10.1111/dme.14781.
    PubMed     Abstract available


  51. SHARMA S, Gillespie P, Hobbins A, Dinneen SF, et al
    Estimating the Cost of Type 1 Diabetes in Ireland.
    Diabet Med. 2021 Dec 27:e14779. doi: 10.1111/dme.14779.
    PubMed     Abstract available


  52. OVERGAARD M, Ravnsborg T, Lohse Z, Bytoft B, et al
    Apolipoprotein D and transthyretin are reduced in female adolescent offspring of women with type 1 diabetes: the EPICOM study.
    Diabet Med. 2021 Dec 23:e14776. doi: 10.1111/dme.14776.
    PubMed     Abstract available


  53. HEALD AH, Stedman M, Horne L, Rea R, et al
    The change in glycaemic control immediately after COVID-19 vaccination in people with type 1 diabetes.
    Diabet Med. 2021 Dec 22:e14774. doi: 10.1111/dme.14774.
    PubMed     Abstract available


  54. FREDRIKSSON M, Persson E, Dahlquist G, Mollsten A, et al
    Risk of cancer in young and middle-aged adults with childhood-onset type 1 diabetes in Sweden - a prospective cohort study.
    Diabet Med. 2021 Dec 19:e14771. doi: 10.1111/dme.14771.
    PubMed     Abstract available


  55. PRIGGE R, McKnight JA, Wild SH, Haynes A, et al
    International comparison of glycaemic control in people with type 1 diabetes: an update and extension.
    Diabet Med. 2021 Dec 10:e14766. doi: 10.1111/dme.14766.
    PubMed     Abstract available


  56. RAJ A, Bansiya V, Evans ML, Boughton CK, et al
    Implementation of dapagliflozin as adjunctive therapy in type 1 diabetes: A single centre real-world experience.
    Diabet Med. 2021 Dec 9:e14764. doi: 10.1111/dme.14764.
    PubMed    


  57. CARREON SA, Cao VT, Anderson BJ, Thompson DI, et al
    "I Don't Sleep Through the Night": Qualitative Study of Sleep in Type 1 Diabetes.
    Diabet Med. 2021 Dec 7:e14763. doi: 10.1111/dme.14763.
    PubMed     Abstract available


  58. FORDE H, Choudhary P, Lumb A, Wilmot E, et al
    Current provision and HCP experiences of remote care delivery and diabetes technology training for people with type 1 diabetes in the UK during the Covid-19 pandemic.
    Diabet Med. 2021 Dec 4:e14755. doi: 10.1111/dme.14755.
    PubMed     Abstract available


  59. ROSE S, Styles SE, Wiltshire EJ, Stanley J, et al
    Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes - extension phase outcomes following a 6-month randomised control trial.
    Diabet Med. 2021 Dec 4:e14756. doi: 10.1111/dme.14756.
    PubMed     Abstract available


  60. MERCHANT HJ, McNeilly AD
    Hypoglycaemia: Still the main drawback of insulin 100 years on: "From man to mouse".
    Diabet Med. 2021;38:e14721.
    PubMed     Abstract available


  61. THABIT H, Lal R, Leelarathna L
    Automated insulin dosing systems: Advances after a century of insulin.
    Diabet Med. 2021;38:e14695.
    PubMed     Abstract available


    November 2021
  62. FRIEL KM, Gillespie P, Coates V, McCauley C, et al
    Estimating and Examining the Costs of Inpatient Diabetes Care in an Irish Public Hospital.
    Diabet Med. 2021 Nov 28:e14753. doi: 10.1111/dme.14753.
    PubMed     Abstract available


  63. PROTHERO L, Lawrenson JG, Cartwright M, Crosby-Nwaobi R, et al
    Barriers and enablers to diabetic eye screening attendance: an interview study with young adults with type 1 diabetes.
    Diabet Med. 2021 Nov 27:e14751. doi: 10.1111/dme.14751.
    PubMed     Abstract available


  64. ZAREMBA N, Robert G, Allan J, Harrison A, et al
    Developing a novel intervention for type 1 diabetes and disordered eating using a participatory action design process: Safe management of people with Type 1 diabetes and EAting Disorders studY (STEADY).
    Diabet Med. 2021 Nov 25:e14749. doi: 10.1111/dme.14749.
    PubMed     Abstract available


  65. DIGUISTO C, Strachan MW, Churchill D, Ayman G, et al
    A Study of Diabetic Ketoacidosis in the Pregnant Population in the United Kingdom. Investigating the incidence, aetiology, management and outcomes.
    Diabet Med. 2021 Nov 15:e14743. doi: 10.1111/dme.14743.
    PubMed     Abstract available


  66. KNOLL C, Peacock S, Waldchen M, Cooper D, et al
    Real-world Evidence on Clinical Outcomes of People with Type 1 Diabetes Using Open-Source and Commercial Automated Insulin Dosing Systems: A Systematic Review.
    Diabet Med. 2021 Nov 12:e14741. doi: 10.1111/dme.14741.
    PubMed     Abstract available


  67. JONES CJ, O'Donnell N, John M, Cooke D, et al
    PaRent InterventiOn to pRevent dIsordered eating in children with TYpe 1 diabetes (PRIORITY): Study protocol for a feasibility randomised controlled trial.
    Diabet Med. 2021 Nov 6:e14738. doi: 10.1111/dme.14738.
    PubMed     Abstract available


  68. VENKATESH N, Astbury N, Thomas MC, Rosado CJ, et al
    Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data.
    Diabet Med. 2021;38:e14608.
    PubMed     Abstract available


    October 2021
  69. YEOH E, Png D, Koh PL, Sum CF, et al
    Glucose Awareness to Motivate and Enable Solutions (GAMES) in Diabetes Mellitus using Flash Glucose Monitoring: A Clinical Programme.
    Diabet Med. 2021 Oct 26:e14733. doi: 10.1111/dme.14733.
    PubMed     Abstract available


  70. TIENHAARA E, Falck AAK, Pokka TM, Tossavainen PH, et al
    The natural history of emerging diabetic retinopathy and microalbuminuria from prepuberty to early adulthood in Type 1 diabetes: A 19-year prospective clinical follow-up study.
    Diabet Med. 2021 Oct 23:e14732. doi: 10.1111/dme.14732.
    PubMed     Abstract available


  71. NARENDRAN P, Tomlinson C, Beese S, Sharma P, et al
    A systematic review and meta-analysis of interventions to preserve insulin-secreting beta cell function in people newly diagnosed with type 1 diabetes: results from intervention studies aimed at improving glucose control.
    Diabet Med. 2021 Oct 22:e14730. doi: 10.1111/dme.14730.
    PubMed     Abstract available


  72. CHATWIN H, Broadley M, Hendrieckx C, Carlton J, et al
    Unmet Support Needs Relating to Hypoglycaemia Among Adults with Type 1 Diabetes: Results of a Multi-Country Web-Based Qualitative Study.
    Diabet Med. 2021 Oct 19:e14727. doi: 10.1111/dme.14727.
    PubMed     Abstract available


  73. DE FRANCO E
    Neonatal diabetes caused by disrupted pancreatic and beta cell development.
    Diabet Med. 2021 Oct 19:e14728. doi: 10.1111/dme.14728.
    PubMed     Abstract available


  74. PASQUINI S, Rinaldi E, Da Prato G, Csermely A, et al
    Growing up with Type 1 Diabetes Mellitus: data from the Verona Diabetes Transition Project.
    Diabet Med. 2021 Oct 17:e14719. doi: 10.1111/dme.14719.
    PubMed     Abstract available


  75. GILLESPIE KM, Fareed R, Mortimer GL
    Four decades of the Bart's Oxford study; improved tests to predict type 1 diabetes.
    Diabet Med. 2021 Oct 16:e14717. doi: 10.1111/dme.14717.
    PubMed     Abstract available


  76. AFI LESLIE K, Richardson SJ, Russell MA, Morgan NG, et al
    Expression of CD47 in the pancreatic beta-cells of young people with recent-onset type 1 diabetes varies according to disease endotype.
    Diabet Med. 2021 Oct 15:e14724. doi: 10.1111/dme.14724.
    PubMed     Abstract available


  77. LONG AE, George G, Williams CL
    Persistence of Islet Autoantibodies after diagnosis in Type 1 Diabetes.
    Diabet Med. 2021 Oct 6:e14712. doi: 10.1111/dme.14712.
    PubMed     Abstract available


  78. SCHIPP J, Skinner TC, Holloway E, Scibilia R, et al
    'We're all on the same team'. Perspectives on the future of artificial pancreas systems by adults in Australia with type 1 diabetes using open-source technologies: A qualitative study.
    Diabet Med. 2021 Oct 2:e14708. doi: 10.1111/dme.14708.
    PubMed     Abstract available


  79. HAUGSTVEDT A, Jorgensen J, Strandberg RB, Nilsen RM, et al
    Sexual dysfunction in women with type 1 diabetes in Norway: a cross-sectional study on prevalence and associations with physical and psychosocial complications.
    Diabet Med. 2021 Oct 1:e14704. doi: 10.1111/dme.14704.
    PubMed     Abstract available


  80. COMMISSARIAT PV, Volkening LK, Butler DA, Dassau E, et al
    Innovative features and functionalities of an artificial pancreas system: What do youth and parents want?
    Diabet Med. 2021;38:e14492.
    PubMed     Abstract available


    September 2021
  81. MORK FCB, Madsen JOB, Jensen AK, Hall GV, et al
    Differences in Insulin Sensitivity in the Partial Remission Phase of Childhood Type 1 Diabetes; a longitudinal cohort study.
    Diabet Med. 2021 Sep 26:e14702. doi: 10.1111/dme.14702.
    PubMed     Abstract available


  82. TATOVIC D, Dayan CM
    Replacing insulin with immunotherapy: time for a paradigm change in Type 1 Diabetes.
    Diabet Med. 2021 Sep 23:e14696. doi: 10.1111/dme.14696.
    PubMed     Abstract available


    August 2021
  83. VAN CAUWENBERGHE J, Enzlin P, Nefs G, Ruige J, et al
    Prevalence of and risk factors for sexual dysfunctions in adults with type 1 or type 2 diabetes: Results from Diabetes MILES - Flanders.
    Diabet Med. 2021 Aug 25:e14676. doi: 10.1111/dme.14676.
    PubMed     Abstract available


  84. CORDON NM, Smart CE, Smith GJ, Davis EA, et al
    The relationship between meal carbohydrate quantity and the insulin to carbohydrate ratio required to maintain glycaemia is non-linear in young people with type 1 diabetes : A randomized crossover trial.
    Diabet Med. 2021 Aug 20:e14675. doi: 10.1111/dme.14675.
    PubMed     Abstract available


  85. LINDKVIST EB, Thorsen SU, Paulsrud C, Thingholm PR, et al
    Association of type 1 diabetes and educational achievement in 16-20-year-olds: A Danish nationwide register study.
    Diabet Med. 2021 Aug 18:e14673. doi: 10.1111/dme.14673.
    PubMed     Abstract available


    July 2021
  86. JENSEN MV, Broadley M, Speight J, Scope A, et al
    The impact of hypoglycaemia on the quality of life of family members of adults with type 1 or type 2 diabetes - a qualitative systematic review.
    Diabet Med. 2021 Jul 30:e14666. doi: 10.1111/dme.14666.
    PubMed     Abstract available


  87. JOENSEN LE, Steenberg JL, Madsen KP, Willaing I, et al
    What people with diabetes in Denmark worry about during the COVID-19 pandemic: a longitudinal study of the first three months of the COVID-19 pandemic.
    Diabet Med. 2021 Jul 30:e14665. doi: 10.1111/dme.14665.
    PubMed     Abstract available


  88. ALLCOCK B, Stewart R, Jackson M
    Psychosocial factors associated with repeat diabetic ketoacidosis in people living with type 1 diabetes: A systematic review.
    Diabet Med. 2021 Jul 29:e14663. doi: 10.1111/dme.14663.
    PubMed     Abstract available


  89. VELAYUTHAM V, Benitez-Aguirre PZ, Liew G, Wong TY, et al
    Baseline extended zone retinal vascular calibers associate with sensory nerve abnormalities in adolescents with type 1 diabetes: a prospective longitudinal study.
    Diabet Med. 2021 Jul 29:e14662. doi: 10.1111/dme.14662.
    PubMed     Abstract available


  90. NAGEL KE, Dearth-Wesley T, Herman AN, Smith HG, et al
    Diabetes distress and glycaemic control in young adults with type 1 diabetes: associations by use of insulin pumps and continuous glucose monitors.
    Diabet Med. 2021 Jul 26:e14660. doi: 10.1111/dme.14660.
    PubMed     Abstract available


  91. UDUKU C, Pendolino V, Godsland I, Oliver N, et al
    Cross-sectional analysis of emergency hypoglycaemia and outcome predictors among people with diabetes in an urban population.
    Diabet Med. 2021 Jul 19:e14654. doi: 10.1111/dme.14654.
    PubMed     Abstract available


  92. CECILIA-COSTA R, Hansmann M, McGill DE, Volkening LK, et al
    Association of Executive Function Problems and Disordered Eating Behaviors in Teens with Type 1 Diabetes.
    Diabet Med. 2021 Jul 17:e14652. doi: 10.1111/dme.14652.
    PubMed     Abstract available


  93. WYLIE TA, Shah C, Burgess L, Robertson E, et al
    Optimising the use of technology to support people with diabetes: research recommendations from Diabetes UK's 2019 diabetes and technology workshop.
    Diabet Med. 2021 Jul 16:e14647. doi: 10.1111/dme.14647.
    PubMed     Abstract available


  94. SMITH TA, Marlow AA, King BR, Smart CE, et al
    Insulin strategies for dietary fat and protein in type 1 diabetes: A systematic review.
    Diabet Med. 2021 Jul 12:e14641. doi: 10.1111/dme.14641.
    PubMed     Abstract available


  95. MCGLACKEN-BYRNE SM, Drew SE, Turner K, Peters C, et al
    The SARS-CoV-2 Pandemic Is Associated With Increased Severity Of Presentation Of Childhood Onset Type 1 Diabetes Mellitus: A Multicentre Study Of The First COVID-19 Wave.
    Diabet Med. 2021 Jul 10:e14640. doi: 10.1111/dme.14640.
    PubMed     Abstract available


  96. PENNO MA, Anderson AJ, Thomson RL, McGorm K, et al
    Evaluation of protocol amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) study during the COVID-19 pandemic.
    Diabet Med. 2021 Jul 8:e14638. doi: 10.1111/dme.14638.
    PubMed     Abstract available


  97. PATTON SR, Feldman K, Majidi S, Noser A, et al
    Identifying HbA1c Trajectories and Modifiable Risk Factors of Trajectories in 5-9-year-olds with Recent-Onset Type 1 Diabetes from the United States.
    Diabet Med. 2021 Jul 8:e14637. doi: 10.1111/dme.14637.
    PubMed     Abstract available


    June 2021
  98. OZBEK BT, Modin D, Mogelvang R, Jorgensen PG, et al
    Echocardiographic predictors of long-term adverse cardiovascular outcomes in patients with and without diabetes mellitus: a follow-up analysis of the Copenhagen City Heart Study.
    Diabet Med. 2021 Jun 21:e14627. doi: 10.1111/dme.14627.
    PubMed     Abstract available


  99. HITT TA, Eisenberg J, Surrey LF, Gokli A, et al
    Clinical Case Conundrum: Hyperlactataemia in a Case of Type 1 Diabetes with Chronic Hyperglycaemia.
    Diabet Med. 2021 Jun 21:e14629. doi: 10.1111/dme.14629.
    PubMed     Abstract available


  100. KELLY CS, Berg CA, Lee Tracy E, Staylor K, et al
    Daily Experiences of Type 1 Diabetes Stress across Adulthood.
    Diabet Med. 2021 Jun 21:e14628. doi: 10.1111/dme.14628.
    PubMed     Abstract available


  101. ZABELL V, Ronne ST, Hogsgaard D, Jorgensen R, et al
    "Interventions involving own treatment choice for people living with coexisting severe mental illness and type 1 or 2 diabetes: A scoping review".
    Diabet Med. 2021 Jun 21:e14626. doi: 10.1111/dme.14626.
    PubMed     Abstract available


  102. NG SM, Evans ML
    Widening health inequalities related to Type 1 diabetes care in children and young people in the UK- a time to act now.
    Diabet Med. 2021 Jun 10:e14620. doi: 10.1111/dme.14620.
    PubMed     Abstract available


  103. MOONEY SP, Booth GL, Shulman R, Na Y, et al
    Glycemic Control in Transition-Aged Versus Early Adults with Type 1 Diabetes and the Effect of a Government-Funded Insulin Pump Program.
    Diabet Med. 2021 Jun 2:e14618. doi: 10.1111/dme.14618.
    PubMed     Abstract available


  104. HOLMAN N, Knighton P, Wild SH, Sattar N, et al
    Cohort profile: National Diabetes Audit for England and Wales.
    Diabet Med. 2021 Jun 1:e14616. doi: 10.1111/dme.14616.
    PubMed     Abstract available


  105. SHAPIRA A, Harrington KR, Goethals ER, Volkening LK, et al
    Health-Related Quality of Life (HRQOL) in Youth with Type 1 Diabetes: Associations with Multiple Comorbidities and Mental Health Conditions.
    Diabet Med. 2021 Jun 1:e14617. doi: 10.1111/dme.14617.
    PubMed     Abstract available


  106. MESSER LH, Campbell K, Pyle L, Forlenza GP, et al
    Basal-IQ technology in the real world: satisfaction and reduction of diabetes burden in individuals with type 1 diabetes.
    Diabet Med. 2021;38:e14381.
    PubMed     Abstract available


    May 2021
  107. GERA S, Longendyke RL, Minich NM, Malay S, et al
    The COVID-19 Pandemic and Associated Worsening of Diabetic Ketoacidosis Presentation in Youth.
    Diabet Med. 2021 May 30:e14610. doi: 10.1111/dme.14610.
    PubMed     Abstract available


  108. TRIKI N, Yekutiel N, Levi L, Azuri J, et al
    The effects of continuous glucose monitoring system on patient outcomes and associated costs in a real-world setting.
    Diabet Med. 2021;38:e14518.
    PubMed     Abstract available


  109. HOOGENDOORN CJ, Gonzalez JS, Schechter CB, Flattau A, et al
    Correlates of self-rated health in people with diabetic peripheral neuropathy: a longitudinal study.
    Diabet Med. 2021;38:e14383.
    PubMed     Abstract available


    April 2021
  110. BOGGISS AL, Consedine NS, Schache KR, Wallace-Boyd K, et al
    Exploring the views of adolescents with type 1 diabetes on digital mental health interventions: what functionality and content do they want?
    Diabet Med. 2021 Apr 30:e14591. doi: 10.1111/dme.14591.
    PubMed     Abstract available


  111. SLATSVE KB, Claudi T, Lappegard KT, Jenum AK, et al
    Factors associated with treatment in primary vs specialist care: A population-based study of people with type 2 and type 1 diabetes.
    Diabet Med. 2021 Apr 8:e14580. doi: 10.1111/dme.14580.
    PubMed     Abstract available


  112. PRIESTERROTH L, Grammes J, Clauter M, Kubiak T, et al
    Diabetes Technologies in People with Type 1 Diabetes mellitus and Disordered Eating: A Systematic Review on Continuous Subcutaneous Insulin Infusion, Continuous Glucose Monitoring and Automated Insulin Delivery.
    Diabet Med. 2021 Apr 7:e14581. doi: 10.1111/dme.14581.
    PubMed     Abstract available


  113. HARRISON A, Zaremba N, Brown J, Allan J, et al
    A cognitive behavioural model of the bidirectional relationship between disordered eating and diabetes self-care in people with type 1 diabetes mellitus.
    Diabet Med. 2021 Apr 2:e14578. doi: 10.1111/dme.14578.
    PubMed     Abstract available


  114. ADDALA A, Suttiratana SC, Wong JJ, Lanning MS, et al
    Cost considerations for adoption of diabetes technology are pervasive: a qualitative study of persons living with type 1 diabetes and their families.
    Diabet Med. 2021 Apr 1:e14575. doi: 10.1111/dme.14575.
    PubMed     Abstract available


  115. MURPHY HR
    2020 NICE guideline update: Good news for pregnant women with type 1 diabetes and past or current gestational diabetes.
    Diabet Med. 2021 Apr 1:e14576. doi: 10.1111/dme.14576.
    PubMed     Abstract available


    March 2021
  116. REID L, Baxter F, Forbes S
    Effects of Islet Transplantation on Microvascular and Macrovascular Complications in Type 1 Diabetes.
    Diabet Med. 2021 Mar 29:e14570. doi: 10.1111/dme.14570.
    PubMed     Abstract available


  117. SILVESTRI F, Mastrangelo M, Costantino F, Masini M, et al
    Contemporary Onset Of Atypical Chronic Inflammatory Demyelinating Polyradiculoneuropathy And Type 1 Diabetes In An Adolescent.
    Diabet Med. 2021 Mar 27:e14563. doi: 10.1111/dme.14563.
    PubMed     Abstract available


  118. SCHOFIELD H, Haycocks S, Robinson A, Edmonds M, et al
    Mortality in 98 Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus: Foot Ulcer Location is an Independent Risk Determinant.
    Diabet Med. 2021 Mar 27:e14568. doi: 10.1111/dme.14568.
    PubMed     Abstract available


  119. COOLEN M, Aalders J, Broadley M, Aanstoot HJ, et al
    Hypoglycaemia and diabetes-specific quality of life in adolescents with type 1 diabetes.
    Diabet Med. 2021 Mar 27:e14565. doi: 10.1111/dme.14565.
    PubMed     Abstract available


  120. SNAITH JR, Samocha-Bonet D, Evans J, Liu Z, et al
    Insulin Resistance in Type 1 Diabetes Managed with Metformin (INTIMET): study protocol of a double-blind placebo-controlled, randomised trial.
    Diabet Med. 2021 Mar 27:e14564. doi: 10.1111/dme.14564.
    PubMed     Abstract available


  121. TANENBAUM ML, Zaharieva DP, Addala A, Ngo J, et al
    "I was ready for it at the beginning": Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis.
    Diabet Med. 2021 Mar 27:e14567. doi: 10.1111/dme.14567.
    PubMed     Abstract available


  122. OLIVER N
    A complex archetype.
    Diabet Med. 2021;38:e14533.
    PubMed    


  123. O'NEILL S
    Update on technologies, medicines and treatments.
    Diabet Med. 2021;38:e14516.
    PubMed    


  124. IBFELT EH, Vistisen D, Falberg Ronn P, Porksen S, et al
    Association between glycaemic outcome and BMI in Danish children with type 1 diabetes in 2000-2018: a nationwide population-based study.
    Diabet Med. 2021;38:e14401.
    PubMed     Abstract available


  125. HANNA KM, Kupzyk KA, Hansen JR, Jones-Ryan ML, et al
    Association of habits, triggers, glycaemic control, routines, stress and impulse control among emerging adults with type 1 diabetes.
    Diabet Med. 2021;38:e14370.
    PubMed     Abstract available


    February 2021
  126. STANTON-FAY SH, Hamilton K, Chadwick PM, Lorencatto F, et al
    The DAFNEplus programme for sustained type 1 diabetes self-management: Intervention development using the Behaviour Change Wheel.
    Diabet Med. 2021 Feb 22:e14548. doi: 10.1111/dme.14548.
    PubMed     Abstract available


  127. MILLER RG, Orchard TJ, Onengut-Gumuscu S, Chen WM, et al
    Heterogeneous Long-Term Trajectories of Glycaemic Control in Type 1 Diabetes.
    Diabet Med. 2021 Feb 19:e14545. doi: 10.1111/dme.14545.
    PubMed     Abstract available


  128. MEBRAHTU G, Maniam J, James S, Ogle GD, et al
    High incidence of type 1 diabetes in adolescents and young adults in Eritrea.
    Diabet Med. 2021 Feb 15:e14544. doi: 10.1111/dme.14544.
    PubMed     Abstract available


  129. SAUNDERS I, Bain SC
    A woman with poorly controlled type 1 diabetes and pruritic papules on her buttocks.
    Diabet Med. 2021 Feb 10:e14539. doi: 10.1111/dme.14539.
    PubMed     Abstract available


  130. STRACHAN M, Foteinopoulou E
    Response to Comment on "Impact of Routine Clinic Measurement of Random Serum C-peptide in People with a Clinician Diagnosis of Type 1 Diabetes" doi:10.1111/dme.14449.
    Diabet Med. 2021 Feb 5:e14537. doi: 10.1111/dme.14537.
    PubMed     Abstract available


  131. HERNAR I, Graue M, Strandberg RB, Lie SS, et al
    Young adults with type 1 diabetes and their experiences with diabetes follow-up and participation in the DiaPROM pilot trial: a qualitative study.
    Diabet Med. 2021 Feb 5:e14535. doi: 10.1111/dme.14535.
    PubMed     Abstract available


  132. THOMAS RL, Cheung WY, Rafferty JM, Luzio SD, et al
    Characteristics of repeat non-attenders at Diabetes Eye Screening Wales, a national community-based diabetes related retinopathy screening service, during 2003 - 2018.
    Diabet Med. 2021 Feb 5:e14536. doi: 10.1111/dme.14536.
    PubMed     Abstract available


  133. LEELARATHNA L, Thabit H, Hovorka R, Evans M, et al
    Estimated HbA1c and glucose management indicator (GMI): are they the same?
    Diabet Med. 2021;38:e14423.
    PubMed    


  134. BARROS BSV, Santos DC, Melo LGN, Pizarro MH, et al
    Genomic ancestry and metabolic syndrome in individuals with type 1 diabetes from an admixed population: a multicentre, cross-sectional study in Brazil.
    Diabet Med. 2021;38:e14400.
    PubMed     Abstract available


  135. LEE AS, Twigg SM, Flack JR
    Metabolic syndrome in type 1 diabetes and its association with diabetes complications.
    Diabet Med. 2021;38:e14376.
    PubMed     Abstract available


  136. ASHRAFI S, Taylor D, Tang TS
    Moving Beyond "Don't Ask, Don't Tell": Mental health needs of adults with type 1 diabetes in rural and remote regions of British Columbia (BC).
    Diabet Med. 2021 Feb 1:e14534. doi: 10.1111/dme.14534.
    PubMed     Abstract available


    January 2021
  137. HELLIWELL R, Warnes H, Kietsiriroje N, Campbell M, et al
    Body mass index, estimated glucose disposal rate and vascular complications in Type 1 Diabetes: Beyond Glycated Haemoglobin.
    Diabet Med. 2021 Jan 27:e14529. doi: 10.1111/dme.14529.
    PubMed     Abstract available


  138. LIN R, Brown F, James S, Jones J, et al
    Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus.
    Diabet Med. 2021 Jan 26:e14528. doi: 10.1111/dme.14528.
    PubMed     Abstract available


  139. HOLMES-TRUSCOTT E, Cooke DD, Hendrieckx C, Coates EJ, et al
    A comparison of the acceptability and psychometric properties of scales assessing the impact of type 1 diabetes on quality of life - Results of 'YourSAY: Quality of Life'.
    Diabet Med. 2021 Jan 14:e14524. doi: 10.1111/dme.14524.
    PubMed     Abstract available


  140. HENDRIECKX C, Morrison M, Audehm R, Barry A, et al
    Women with type 1 diabetes and women with type 2 diabetes differ in knowledge and beliefs about contraception and pregnancy.
    Diabet Med. 2021 Jan 12:e14521. doi: 10.1111/dme.14521.
    PubMed     Abstract available


  141. SMITH TA, Smart CE, Howley PP, Lopez PE, et al
    For a high fat- high protein breakfast, preprandial administration of 125% of the insulin dose improves postprandial glycaemic excursions in people with Type 1 diabetes using multiple daily injections: a cross-over trial.
    Diabet Med. 2021 Jan 9:e14512. doi: 10.1111/dme.14512.
    PubMed     Abstract available


  142. PATEL SK, Fourlanos S, Greenfield JR
    Comment on "Impact of Routine Clinic Measurement of Random Serum C-peptide in People with a Clinician Diagnosis of Type 1 Diabetes".
    Diabet Med. 2021 Jan 8:e14513. doi: 10.1111/dme.14513.
    PubMed     Abstract available


  143. SMITH TA, Smart CE, Fuery MEJ, Howley PP, et al
    In Children and Young people with type 1 Diabetes using Pump Therapy an additional 40% of the Insulin dose for a High fat, High Protein breakfast improves postprandial glycaemic excursions: A cross- over trial.
    Diabet Med. 2021 Jan 6:e14511. doi: 10.1111/dme.14511.
    PubMed     Abstract available


  144. APPERLEY LJ, Clemente M, Sultana P, Ng SM, et al
    Social deprivation affects the practice of routinely downloading blood glucose data at home for families and children with type 1 diabetes.
    Diabet Med. 2021;38:e14403.
    PubMed    


    December 2020
  145. GOETHALS ER, Volkening LK, Tinsley L, Laffel LM, et al
    Ready or not? Greater readiness for independent self-care predicts better self-management but not HbA1c in teens with type 1 diabetes.
    Diabet Med. 2020 Dec 29:e14507. doi: 10.1111/dme.14507.
    PubMed     Abstract available


  146. BRADY EM, Bodicoat DH, Zaccardi F, Seidu S, et al
    Effectiveness of the Transformation Model, a model of care that integrates diabetes services across primary, secondary and community care: A retrospective study.
    Diabet Med. 2020 Dec 24:e14504. doi: 10.1111/dme.14504.
    PubMed     Abstract available


  147. FORDE R, Arente L, Ausili D, De Backer K, et al
    The Impact of the COVID-19 Pandemic on People with Diabetes and Diabetes Services: A pan-European Survey of Diabetes Specialist Nurses undertaken by the Foundation of European Nurses in Diabetes survey consortium.
    Diabet Med. 2020 Dec 14:e14498. doi: 10.1111/dme.14498.
    PubMed     Abstract available


  148. ROWE CW, Watkins B, Brown K, Delbridge M, et al
    Efficacy and safety of the Pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in Type 1 and Type 2 diabetes.
    Diabet Med. 2020 Dec 4:e14489. doi: 10.1111/dme.14489.
    PubMed     Abstract available


  149. JAMES S, Pryke A, Cusumano J, Jenkins A, et al
    20-Year Outcomes of Childhood-Onset Type 1 Diabetes: the CANDID Incident Cohort Survey.
    Diabet Med. 2020 Dec 3:e14473. doi: 10.1111/dme.14473.
    PubMed     Abstract available


    November 2020
  150. BEVERLY EA, Ritholz MD, Dhanyamraju K
    The Buffering Effect of Social Support on Diabetes Distress and Depressive Symptoms in Adults with Type 1 and Type 2 Diabetes.
    Diabet Med. 2020 Nov 30:e14472. doi: 10.1111/dme.14472.
    PubMed     Abstract available


  151. KENNY E, O'Malley R, Roche K, Morrissey E, et al
    Diabetes distress instruments in adults with Type 1 diabetes: a systematic review using the COSMIN (COnsensus-based Standards for the selection of health status Measurement INstruments) checklist.
    Diabet Med. 2020 Nov 24:e14468. doi: 10.1111/dme.14468.
    PubMed     Abstract available


  152. SCHLUTER S, Freckmann G, Heinemann L, Wintergerst P, et al
    Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: a real-world multicentre prospective study in 120 adults with type 1 diabetes.
    Diabet Med. 2020 Nov 23:e14467. doi: 10.1111/dme.14467.
    PubMed     Abstract available


  153. ALTMAN JJ, Niarra R, Balkau B, Vincent-Cassy C, et al
    The JUBILE cohort: Quality of life after more than 40 years with type 1 diabetes.
    Diabet Med. 2020 Nov 16:e14460. doi: 10.1111/dme.14460.
    PubMed     Abstract available


  154. DASHORA U, Patel DC, Gregory R, Winocour P, et al
    Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020).
    Diabet Med. 2020 Nov 11:e14458. doi: 10.1111/dme.14458.
    PubMed     Abstract available


  155. ROTBAIN CUROVIC V, Theilade S, Winther SA, Tofte N, et al
    Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes.
    Diabet Med. 2020 Nov 11:e14459. doi: 10.1111/dme.14459.
    PubMed     Abstract available


  156. THOMSEN NOB, Dahlin LB
    Vibrotactile Sense Five years after Carpal Tunnel Release in People with Diabetes.
    Diabet Med. 2020 Nov 10:e14453. doi: 10.1111/dme.14453.
    PubMed     Abstract available


  157. HINTON W, Nemeth B, de Lusignan S, Field B, et al
    Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism.
    Diabet Med. 2020 Nov 9:e14452. doi: 10.1111/dme.14452.
    PubMed     Abstract available


  158. RAMA CHANDRAN S, Zaremba N, Harrison A, Choudhary P, et al
    Disordered eating in women with type 1 diabetes: Continuous glucose monitoring reveals the complex interactions of glycaemia, self-care behaviour and emotion.
    Diabet Med. 2020 Nov 3:e14446. doi: 10.1111/dme.14446.
    PubMed     Abstract available


  159. AUKUSO L, De Lange M, Wlitshire E, Jefferies C, et al
    Youth and non-European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes.
    Diabet Med. 2020 Nov 1:e14450. doi: 10.1111/dme.14450.
    PubMed     Abstract available


  160. FOTEINOPOULOU E, Clarke CAL, Pattenden RJ, Ritchie SA, et al
    Impact of Routine Clinic Measurement of Serum C-Peptide in People with a Clinician-Diagnosis of Type 1 Diabetes.
    Diabet Med. 2020 Nov 1:e14449. doi: 10.1111/dme.14449.
    PubMed     Abstract available


    October 2020
  161. DOVER AR, Strachan MWJ, McKnight JA, Stimson RH, et al
    Socioeconomic deprivation, technology use, C-peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes.
    Diabet Med. 2020 Oct 31:e14445. doi: 10.1111/dme.14445.
    PubMed     Abstract available


  162. ERDAL B, Caferoglu Z, Hatipoglu N
    The comparison of two mealtime insulin dosing algorithms for high and low glycaemic index meals in adolescents with type 1 diabetes.
    Diabet Med. 2020 Oct 29:e14444. doi: 10.1111/dme.14444.
    PubMed     Abstract available


  163. GRAY AL, Campbell MS, Berg CA, Wiebe DJ, et al
    Qualitative Analysis of Helpful and Unhelpful Aspects of Social Relationships Among Young Adults with Type 1 Diabetes.
    Diabet Med. 2020 Oct 27:e14441. doi: 10.1111/dme.14441.
    PubMed     Abstract available


  164. LEUNG JM, Tang TS, Lim CE, Laffel LM, et al
    The 4 I's of adolescent transition in type 1 diabetes care: a qualitative study.
    Diabet Med. 2020 Oct 27:e14443. doi: 10.1111/dme.14443.
    PubMed     Abstract available


  165. JANUSZEWSKI AS, Xu D, Cho YH, Benitez-Aguirre P, et al
    Skin autofluorescence in people with type 1 diabetes and people without diabetes: an eight-decade cross-sectional study with evidence of accelerated aging and associations with complications.
    Diabet Med. 2020 Oct 20:e14432. doi: 10.1111/dme.14432.
    PubMed     Abstract available


  166. HAMILTON K, Stanton-Fay SH, Chadwick PM, Lorencatto F, et al
    Sustained type 1 diabetes self-management: Specifying the behaviours involved and their influences.
    Diabet Med. 2020 Oct 19:e14430. doi: 10.1111/dme.14430.
    PubMed     Abstract available


  167. JOHNSON E, DeJonckheere M, Oliverio A, Brown KS, et al
    A theoretical model of contraceptive decision making and behavior in diabetes: A qualitative application of the Health Belief Model.
    Diabet Med. 2020 Oct 19:e14434. doi: 10.1111/dme.14434.
    PubMed     Abstract available


  168. BROWN RE, Vienneau T, Aronson R
    Canadian Real-World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): evidence from the LMC Diabetes Registry.
    Diabet Med. 2020 Oct 11:e14420. doi: 10.1111/dme.14420.
    PubMed     Abstract available


  169. HAUGSTVEDT A, Hernar I, Graue M, Strandberg RB, et al
    Nurses' and physicians' experiences with diabetes consultations and the use of dialogue tools in the DiaPROM pilot trial: a qualitative study.
    Diabet Med. 2020 Oct 9:e14419. doi: 10.1111/dme.14419.
    PubMed     Abstract available


    September 2020
  170. VON SENGBUSCH S, Doerdelmann J, Lemke S, Lange K, et al
    Parental expectations before and after 12-month experience with video consultations combined with regular outpatient care for children with type 1 diabetes: a qualitative study.
    Diabet Med. 2020 Sep 24:e14410. doi: 10.1111/dme.14410.
    PubMed     Abstract available


    August 2020
  171. SCHULTZ AA, Wad JL, Willaing I, Norgaard K, et al
    Achieving a useful and person-centred diabetes consultation is a shared responsibility between diabetologists and people with diabetes: a qualitative study of perspectives from people with type 1 diabetes.
    Diabet Med. 2020 Aug 15:e14382. doi: 10.1111/dme.14382.
    PubMed     Abstract available


    April 2020
  172. OLIVER N, Holt RIG
    The James Lind Alliance Research Priorities for Diabetes revisited.
    Diabet Med. 2020;37:511-512.
    PubMed    


    March 2020
  173. DASH K, Goyder EC, Quirk H
    A qualitative synthesis of the perceived factors that affect participation in physical activity among children and adolescents with type 1 diabetes.
    Diabet Med. 2020 Mar 17. doi: 10.1111/dme.14299.
    PubMed     Abstract available


    February 2020
  174. LANDI G, Andreozzi MS, Pakenham K, Grandi S, et al
    Psychosocial adjustment of young offspring in the context of parental type 1 and type 2 diabetes: a systematic review.
    Diabet Med. 2020 Feb 11. doi: 10.1111/dme.14271.
    PubMed     Abstract available


  175. HELLER SR, Gianfrancesco C, Taylor C, Elliott J, et al
    What are the characteristics of the best type 1 diabetes patient education programmes (from diagnosis to long-term care), do they improve outcomes and what is required to make them more effective?
    Diabet Med. 2020 Feb 8. doi: 10.1111/dme.14268.
    PubMed     Abstract available


  176. WINKLEY K, Upsher R, Stahl D, Pollard D, et al
    Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes.
    Diabet Med. 2020 Feb 5. doi: 10.1111/dme.14264.
    PubMed     Abstract available


    January 2020
  177. FOKKERT M, van Dijk PR, Edens M, Diez A, et al
    Performance of continuous glucose monitoring devices during intensive exercise conditions in people with diabetes: the Mont Blanc experience.
    Diabet Med. 2020 Jan 31. doi: 10.1111/dme.14259.
    PubMed     Abstract available


  178. VAN NAME MA, Cheng P, Gal RL, Kollman C, et al
    Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium registries: comparing clinical characteristics and glycaemic control.
    Diabet Med. 2020 Jan 14. doi: 10.1111/dme.14233.
    PubMed     Abstract available


    December 2019
  179. MCKNIGHT JA, Ochs A, Mair C, McKnight O, et al
    The effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in Scotland.
    Diabet Med. 2019 Dec 23. doi: 10.1111/dme.14223.
    PubMed     Abstract available


  180. VAN DUINKERKEN E, Snoek FJ, de Wit M
    The cognitive and psychological effects of living with type 1 diabetes: a narrative review.
    Diabet Med. 2019 Dec 18. doi: 10.1111/dme.14216.
    PubMed     Abstract available


  181. GRAMMES J, Kustner E, Dapp A, Hummel M, et al
    Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry.
    Diabet Med. 2019 Dec 18. doi: 10.1111/dme.14218.
    PubMed     Abstract available


  182. NEFS G, Bazelmans E, Donga E, Tack CJ, et al
    Sweet dreams or bitter nightmare: a narrative review of 25 years of research on the role of sleep in diabetes and the contributions of behavioural science.
    Diabet Med. 2019 Dec 12. doi: 10.1111/dme.14211.
    PubMed     Abstract available


  183. HENDRIECKX C, Gonder-Frederick L, Heller SR, Snoek FJ, et al
    How has psycho-behavioural research advanced our understanding of hypoglycaemia in type 1 diabetes?
    Diabet Med. 2019 Dec 8. doi: 10.1111/dme.14205.
    PubMed     Abstract available


  184. SEAQUIST ER, Blonde L, McGill JB, Heller SR, et al
    Hypoglycaemia is reduced with use of inhaled Technosphere((R)) Insulin relative to insulin aspart in type 1 diabetes mellitus.
    Diabet Med. 2019 Dec 6. doi: 10.1111/dme.14202.
    PubMed     Abstract available


  185. BROADLEY MM, Zaremba N, Andrew B, Ismail K, et al
    25 Years of psychological research investigating disordered eating in people with diabetes: what have we learnt?
    Diabet Med. 2019 Dec 3. doi: 10.1111/dme.14197.
    PubMed     Abstract available


    November 2019
  186. BOUCHER SE, Aum SH, Crocket HR, Wiltshire EJ, et al
    Exploring parental perspectives after commencement of flash glucose monitoring for type 1 diabetes in adolescents and young adults not meeting glycaemic targets: a qualitative study.
    Diabet Med. 2019 Nov 26. doi: 10.1111/dme.14188.
    PubMed     Abstract available


  187. WONG JJ, Addala A, Naranjo D, Hood KK, et al
    Monetary reinforcement for self-monitoring of blood glucose among young people with type 1 diabetes: evaluating effects on psychosocial functioning.
    Diabet Med. 2019 Nov 8. doi: 10.1111/dme.14174.
    PubMed     Abstract available


    October 2019
  188. MCCOLLUM DC, O'Grady MJ
    Diminished school-based support for the management of type 1 diabetes in adolescents compared to younger children.
    Diabet Med. 2019 Oct 26. doi: 10.1111/dme.14160.
    PubMed     Abstract available


    September 2019
  189. PASTOR A, Conn J, O'Brien CL, Teng J, et al
    Clinicians feel comfortable discussing alcohol but not illicit drug use with young adults with type 1 diabetes: a survey of clinicians.
    Diabet Med. 2019 Sep 17. doi: 10.1111/dme.14136.
    PubMed     Abstract available


  190. KORDONOURI O, Lange K, Biester T, Datz N, et al
    Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.
    Diabet Med. 2019 Sep 9. doi: 10.1111/dme.14130.
    PubMed     Abstract available


    August 2019
  191. COOPER JG, Bakke A, Dalen I, Carlsen S, et al
    Factors associated with glycaemic control in adults with Type 1 diabetes: a registry-based analysis including 7601 individuals from 34 centres in Norway.
    Diabet Med. 2019 Aug 30. doi: 10.1111/dme.14123.
    PubMed     Abstract available


  192. WISTING L, Snoek F
    Terminology matters: 'diabulimia' is insufficient to describe eating disorders in individuals with Type 1 diabetes.
    Diabet Med. 2019 Aug 16. doi: 10.1111/dme.14108.
    PubMed    


    July 2019
  193. RAWDON C, Gallagher P, Glacken M, Swallow V, et al
    Parent and adolescent communication with healthcare professionals about Type 1 diabetes management at adolescents' outpatient clinic appointments.
    Diabet Med. 2019 Jul 11. doi: 10.1111/dme.14075.
    PubMed     Abstract available


  194. NARENDRAN P, Greenfield S, Troughton J, Doherty Y, et al
    Development of a group structured education programme to support safe exercise in people with Type 1 diabetes: the EXTOD education programme.
    Diabet Med. 2019 Jul 2. doi: 10.1111/dme.14064.
    PubMed     Abstract available


    June 2019
  195. KENOWITZ JR, Hoogendoorn CJ, Commissariat PV, Gonzalez JS, et al
    Diabetes-specific self-esteem, self-care and glycaemic control among adolescents with Type 1 diabetes.
    Diabet Med. 2019 Jun 19. doi: 10.1111/dme.14056.
    PubMed     Abstract available


    February 2019
  196. AVARI P, Reddy M, Oliver N
    Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)?
    Diabet Med. 2019 Feb 25. doi: 10.1111/dme.13942.
    PubMed     Abstract available


    January 2019
  197. LIVINGSTONE R, Boyle JG, Petrie JR
    How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes?
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13911.
    PubMed     Abstract available


  198. GROSSOEHME DH, Smith E, Standiford D, Morwessel N, et al
    Understanding adolescent and parent acceptability and feasibility experience in a large Type 1 diabetes mellitus behavioural trial.
    Diabet Med. 2019 Jan 30. doi: 10.1111/dme.13913.
    PubMed     Abstract available


    December 2018
  199. MISRA S, Mathieu C
    Are newer insulin analogues better for people with Type 1 diabetes?
    Diabet Med. 2018 Dec 26. doi: 10.1111/dme.13891.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: